Exelon (EXC)
(Delayed Data from NSDQ)
$40.77 USD
+0.22 (0.54%)
Updated Oct 1, 2024 04:00 PM ET
Pre-Market: $40.75 -0.02 (-0.05%) 9:16 AM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$40.77 USD
+0.22 (0.54%)
Updated Oct 1, 2024 04:00 PM ET
Pre-Market: $40.75 -0.02 (-0.05%) 9:16 AM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Zacks News
Top Research Reports for Intuitive Surgical, HCA Healthcare & Exelon
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Exelon (EXC).
Zacks.com featured highlights include: ArcBest, Zions, Covenant Transportation, Seaspan and Exelon
by Zacks Equity Research
Zacks.com featured highlights include: ArcBest, Zions, Covenant Transportation, Seaspan and Exelon
5 Value Picks With Strikingly Low EV/EBITDA Ratios
by Anindya Barman
We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Top Stock Reports for Eli Lilly, Anthem & BlackRock
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly (LLY), Anthem (ANTM) and BlackRock (BLK).
Exelon's (EXC) Unit Gets Consent to Reduce Rates in 2019
by Zacks Equity Research
Exelon's unit, ComEd receives approval from The Illinois Commerce Commission to lower delivery charges from January 2019.
Exelon (EXC) Up 6.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Exelon (EXC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Add Exelon (EXC) to Your Portfolio
by Zacks Equity Research
Exelon (EXC) to provide better returns to investors, courtesy of these four factors.
Are Investors Undervaluing Exelon (EXC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Research Reports for Pfizer, Cisco & Southern Company
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), Cisco (CSCO) and Southern Company (SO).
FirstEnergy (FE) to Pass Tax Savings, Reduce Utility Bills
by Zacks Equity Research
FirstEnergy' (FE) aims to refund $900-million tax savings to customers.
Zacks.com highlights: ArcBest, Covenant Transportation Group, Capital One Financial, Zions Bancorp. and Exelon
by Zacks Equity Research
Zacks.com highlights: ArcBest, Covenant Transportation Group, Capital One Financial, Zions Bancorp. and Exelon
Tap These 5 Value Stocks With Enticing EV/EBITDA Ratios
by Anindya Barman
We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a companys valuation and earnings potential.
Retail Unit Helps Southern Company (SO) Beat Q3 Earnings
by Nilanjan Choudhury
Southern Company's (SO) total retail sales rose 3.9%, with residential, commercial and industrial sales all improving.
Eversource's (ES) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
Eversource Energy (ES) surpasses Q3 earnings estimates, courtesy of strong contribution from Electric and Water distribution segments.
Exelon (EXC) Posts In-Line Q3 Earnings, Tweaks Guidance
by Zacks Equity Research
Exelon's (EXC) Q3 earnings are in line with expectation. The company continues to find ways to save costs, which drives growth.
Exelon (EXC) Q3 Earnings Match Estimates
by Zacks Equity Research
Exelon (EXC) delivered earnings and revenue surprises of 0.00% and 11.68%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Utility Stocks' Q3 Earnings Due on Nov 1: D, EXC, ES & More
by Zacks Equity Research
Let us on focus utilities scheduled to report third quarter earnings on Nov 1, 2018.
EXC or PNW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EXC vs. PNW: Which Stock Is the Better Value Option?
Are You Looking for a High-Growth Dividend Stock? Exelon (EXC) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Exelon (EXC) have what it takes? Let's find out.
Is a Surprise Coming for Exelon (EXC) This Earnings Season?
by Zacks Equity Research
Exelon (EXC) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
The Zacks Analyst Blog Highlights: National Fuel Gas, Dominion Energy, American Electric Power, WEC Energy Group and Exelon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: National Fuel Gas, Dominion Energy, American Electric Power, WEC Energy Group and Exelon
What's in Store for Eversource Energy (ES) in Q3 Earnings?
by Zacks Equity Research
Eversource Energy (ES) is expected to beat earnings estimates when it releases third-quarter results on Nov 2.
US-China Trade War Set to Escalate: 5 Safe Utility Picks
by Swarup Gupta
Investing in utilities stocks, which offer lucrative dividends, is a smart option.
Is a Beat in Store for Exelon (EXC) This Earnings Season?
by Zacks Equity Research
Exelon (EXC) is expected to make an impression with earnings beat in Q3.
Why Exelon (EXC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Exelon (EXC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.